ML141

CAS No. 71203-35-5

ML141 ( CID2950007 )

Catalog No. M15727 CAS No. 71203-35-5

ML141 is a potent, selective and reversible non-competitive inhibitor of Rho family GTPase cdc42 with IC50 of 200 nM.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 41 In Stock
5MG 59 In Stock
10MG 101 In Stock
25MG 212 In Stock
50MG 385 In Stock
100MG 551 In Stock
500MG 1188 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ML141
  • Note
    Research use only, not for human use.
  • Brief Description
    ML141 is a potent, selective and reversible non-competitive inhibitor of Rho family GTPase cdc42 with IC50 of 200 nM.
  • Description
    ML141 is a potent, selective and reversible non-competitive inhibitor of Rho family GTPase cdc42 with IC50 of 200 nM.
  • Synonyms
    CID2950007
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    cdc42
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    71203-35-5
  • Formula Weight
    407.49
  • Molecular Formula
    C22H21N3O3S
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 81 mg/mL warmed (198.77 mM)
  • SMILES
    O=S(C1=CC=C(N2N=C(C3=CC=CC=C3)CC2C4=CC=C(OC)C=C4)C=C1)(N)=O
  • Chemical Name
    4-[4,5-dihydro-5-(4-methoxyphenyl)-3-phenyl-1H-pyrazol-1-yl]-benzenesulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Chen HY, et al. EMBO Mol Med. 2013, 5(5), 723-736.
molnova catalog
related products
  • Voruciclib

    A potent, selective and orally bioavailable CDK9 inhibitor with Ki of 0.63 nM and 1.68 nM for CDK9/cyclinT2 and CDK9/cyclinT1, respectively.

  • CDK4-IN-1

    CDK4 inhibitor is a novel and specific CDK4/Cyclin D1 inhibitor with an IC50 of 10 nM.

  • Indirubin-3-monoxime

    Indirubin-3-monoxime is an effective inhibitor of cyclin-dependent protein kinases, and may play an obligate role in neuronal apoptosis in Alzheimer's disease.